Sutro Biopharma Inc (STRO)
3.83
-0.11
(-2.79%)
USD |
NASDAQ |
May 03, 16:00
3.84
+0.01
(+0.26%)
After-Hours: 20:00
Sutro Biopharma Total Assets (Quarterly): 470.74M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 470.74M |
| September 30, 2023 | 431.73M |
| June 30, 2023 | 464.90M |
| March 31, 2023 | 358.02M |
| December 31, 2022 | 406.94M |
| September 30, 2022 | 400.70M |
| June 30, 2022 | 385.62M |
| March 31, 2022 | 303.68M |
| December 31, 2021 | 341.41M |
| September 30, 2021 | 371.47M |
| June 30, 2021 | 359.79M |
| March 31, 2021 | 358.53M |
| Date | Value |
|---|---|
| December 31, 2020 | 394.11M |
| September 30, 2020 | 307.24M |
| June 30, 2020 | 277.54M |
| March 31, 2020 | 153.88M |
| December 31, 2019 | 156.37M |
| September 30, 2019 | 171.68M |
| June 30, 2019 | 188.81M |
| March 31, 2019 | 202.46M |
| December 31, 2018 | 223.14M |
| September 30, 2018 | 145.03M |
| June 30, 2018 | 45.18M |
| December 31, 2017 | 40.77M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
153.88M
Minimum
Mar 2020
470.74M
Maximum
Dec 2023
331.74M
Average
358.53M
Median
Mar 2021
Total Assets (Quarterly) Benchmarks
| AnaptysBio Inc | 452.39M |
| ABVC BioPharma Inc | 14.49M |
| Reviva Pharmaceuticals Holdings Inc | 23.70M |
| Flora Growth Corp | 23.63M |
| Journey Medical Corp | 76.85M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 321.09M |
| Shareholders Equity (Quarterly) | 149.65M |
| Debt to Equity Ratio | 0.0271 |
| Current Ratio | 4.497 |
| Net Debt Paydown Yield | 1.16% |